Patients who have gastric cancer surgery followed by chemotherapy have an associated decreased risk of death and improved disease-free survival compared to patients who have surgery alone, according to a new French-led analysis of previous studies.
Cancer
Modern management of cancer pain
Mary Anne Kenny reports from this year’s Cephalon Palliative Care Symposium, which focused on quality in training and research {openx:269} At this year’s Cephalon Palliative Care Symposium, held on 16-17 April, experts spoke about the latest advances in cancer pain management and in palliative care education.
Melanoma survivors at higher recurrence risk
Research has shown that survivors of skin cancer are nine times as likely to develop a second melanoma as the general populace, writes Aoife Connors {openx:269} Survivors of non-melanoma cancer are most likely to develop recurring melanomas and face an increased risk of other cancers.
Deciphering the genetic riddle of cancer
Dr John B.
Vitamin D linked to lower risk of colon cancer
High blood levels of vitamin D are associated with a lower risk of colon cancer, according to a large European study.
Rise in HPV cancer has serious implications
The rapid rise in cases of oesophageal squamous cell carcinoma that are related to human papillomavirus (HPV) infection has serious implications for health services around the world, researchers have warned.
HPV tests may detect more precancerous cells
As part of a well-established organised screening programme, primary human papillomavirus (HPV) screening with cytology triage is more sensitive than conventional cytology in the detection of cervical intraepithelial neoplasia (CIN) grade III, according to the results of a randomised trial.
IBD extra-intestinal cancer risk elucidated
Patients with Crohn’s disease (CD) have a slightly higher risk of extra-intestinal cancer as compared to a matched background population, a new meta-analysis shows.
HER2 testing and its role in breast cancer
Dr John B.
New steps in prostate cancer treatment
Coinciding with the 60th anniversary of the company, Ferring Pharmaceuticals recently held an event to launch its new and revolutionary prostate cancer treatment.